LiverMultiScan® detected earlier stages of treatable disease in patients with autoimmune hepatitis to allow tailored treatment

March 21, 2022

LiverMultiScan® has achieved nationwide payer coverage for diagnosis and management of NAFLD and other established chronic liver diseases

March 14, 2022

First patient recruited for multi-year collaborative primary sclerosing cholangitis (PSC) pediatric study using Perspectum’s imaging technology to help predict disease progression and guide patient management

January 27, 2022

New meta-analysis finds Perspectum’s non-invasive MRI biomarker cT1 is an effective alternative to biopsy for identifying patients at high risk of liver disease progression

January 12, 2022

Perspectum and HepQuant Announce Partnership to Bring a More Complete Picture of Liver Health

November 01, 2021

Perspectum Expands into Louisiana in Partnership with West Jefferson Medical Center in New Orleans, LA

October 05, 2021

Perspectum Announces Partnership with Datavant to Improve Clinical Trial Recruitment with Connected Data

September 16, 2021

New study finds Perspectum®’s LiverMultiScan® may positively impact patient participation in liver disease care pathways

September 13, 2021

First European guidance on the use of multiparametric MRI in fatty liver disease

September 04, 2021